Mogamulizumab-kpkc Intravenous and Tenofovir Alafenamide Fumarate
Determining the interaction of Mogamulizumab-kpkc Intravenous and Tenofovir Alafenamide Fumarate and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: mogamulizumab
Brand name: Poteligeo
Synonyms: Mogamulizumab
Generic Name: tenofovir alafenamide
Brand name: Vemlidy
Synonyms: Tenofovir Alafenamide
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Mogamulizumab-kpkc Intravenous-Tenofovir Disoproxil Fumarate
- Mogamulizumab-kpkc Intravenous-Tenofovir Disoproxil Fumarate Oral Powder
- Mogamulizumab-kpkc Intravenous-Tenofovir Disoproxil Fumarate Tablets
- Mogamulizumab-kpkc Intravenous-Tenoretic
- Mogamulizumab-kpkc Intravenous-Tenoretic 100
- Mogamulizumab-kpkc Intravenous-Tenoretic 50
- Tenofovir Alafenamide Fumarate-Molindone
- Tenofovir Alafenamide Fumarate-Mometasone (Oral Inhalation)
- Tenofovir Alafenamide Fumarate-Mometasone and Formoterol
- Tenofovir Alafenamide Fumarate-Mometasone and formoterol Inhalation
- Tenofovir Alafenamide Fumarate-Mometasone Cream
- Tenofovir Alafenamide Fumarate-Mometasone Furoate